Fig. 2
From: Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
The interaction prototype of USP21 with (A) Ranmogenin A, (B) Tokorogenin, and (C) BAY-805.
Fig. 2 | Scientific Reports
From: Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
The interaction prototype of USP21 with (A) Ranmogenin A, (B) Tokorogenin, and (C) BAY-805.
